Aliases & Classifications for Hemarthrosis

About this section

Aliases & Descriptions for Hemarthrosis:

Name: Hemarthrosis 11 13 48 37 66
Hemarthrosis Involving Pelvic Region and Thigh 11
Haemarthrosis of the Pelvic Region and Thigh 11
Hemarthrosis of the Pelvic Region and Thigh 11
Hemarthrosis Involving Shoulder Region 11
Hemarthrosis of the Ankle and/or Foot 11
Hemarthrosis Involving Ankle and Foot 11
Haemarthrosis of the Ankle and Foot 11
Hemarthrosis of the Shoulder Region 11
Hemarthrosis of the Ankle and Foot 11
Hemarthrosis of Ankle and/or Foot 11
Hemarthrosis Involving Upper Arm 11
Hemarthrosis Involving Lower Leg 11
 
Hemarthrosis of Shoulder Region 11
Haemarthrosis of Shoulder Joint 11
Hemarthrosis Involving Forearm 11
Hemarthrosis of the Upper Arm 11
Hemarthrosis of the Lower Leg 11
Hemarthrosis of the Forearm 11
Hemarthrosis Involving Hand 11
Hemarthrosis of Upper Arm 11
Hemarthrosis of Lower Leg 11
Hemarthrosis of the Hand 11
Hemarthrosis of Shoulder 11
Hemarthrosis of Forearm 11
Hemarthrosis of Hand 11

Classifications:



External Ids:

Disease Ontology11 DOID:801
ICD1028 M25.0
ICD9CM30 719.1, 719.10
MeSH37 D006395

Summaries for Hemarthrosis

About this section
Wikipedia:69 Hemarthrosis (or haemarthrosis, plural h(a)emarthroses) is a bleeding into joint spaces. It is a common... more...

MalaCards based summary: Hemarthrosis, also known as hemarthrosis involving pelvic region and thigh, is related to factor x deficiency and factor v deficiency, and has symptoms including arthralgia, hemoptysis and metatarsalgia. An important gene associated with Hemarthrosis is F8 (Coagulation Factor VIII), and among its related pathways are Transcription_Role of VDR in regulation of genes involved in osteoporosis and Development_Hedgehog and PTH signaling pathways in bone and cartilage development. Affiliated tissues include bone, b cells and monocytes, and related mouse phenotypes are cardiovascular system and homeostasis/metabolism.

Related Diseases for Hemarthrosis

About this section

Diseases related to Hemarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 81)
idRelated DiseaseScoreTop Affiliating Genes
1factor x deficiency30.6F7, F9
2factor v deficiency28.7F10, F7, F8, F9
3myocardial infarction28.5F10, F13A1, F7, F8
4secondary central precocious puberty10.4F10, F8
5high anorectal malformation10.3F8, F9
6acquired fructose intolerance10.3F8, F9
7allain-babin-demarquez syndrome10.3F8, F9
8diabetic autonomic neuropathy10.3F8, F9
9hemophilia10.3
10inherited blood coagulation disease10.2F13A1, F8
11synovitis10.1
12peripheral focal chorioretinitis10.1F13A1, F8
13papillary adenocarcinoma10.0BGLAP, SPP1
14arthritis10.0
15biermer's disease10.0F10, F8, F9
16thrombophilia due to activated protein c resistance10.0F10, F8, F9
17scurvy10.0
18intracranial arteriovenous malformation10.0BGLAP, SPP1
19nephropathy familial with hyperuricemia10.0F13A1, SPP1
20afibrinogenemia, congenital9.9
21nail disorder, nonsyndromic congenital, 19.9BGLAP, SPP1
22hemophilia a9.9
23acute myocardial infarction9.9
24thrombasthenia9.9
25aneurysm9.9
26pregnancy loss, recurrent 29.9F10, F13A1, F8
27extraskeletal chondroma9.9F8, F9
28transient cerebral ischemia9.9F7, F9
29melanoma9.9F7, F9
30peripheral osteosarcoma9.8BGLAP, SPP1
31glanzmann thrombasthenia9.8
32lipoma9.8
33osteoarthritis9.8
34pigmented villonodular synovitis9.8
35purpura9.8
36arthropathy9.8
37villonodular synovitis9.8
38acquired hemophilia9.8
39esophagus leiomyosarcoma9.8F7, F9
40physical disorder9.8BGLAP, SPP1
41brill-zinsser disease9.7BGLAP, F7
42brain stem angioblastoma9.7BGLAP, SPP1
43pyridoxamine 5'-phosphate oxidase deficiency9.7F8, F9
44rheumatoid arthritis9.7
45systemic lupus erythematosus9.7
46psoriatic arthritis9.7
47hemophilia b9.7
48reflex sympathetic dystrophy9.7
49arteriovenous fistula9.7
50hemangioma9.7

Graphical network of the top 20 diseases related to Hemarthrosis:



Diseases related to hemarthrosis

Symptoms for Hemarthrosis

About this section

UMLS symptoms related to Hemarthrosis:


arthralgia, hemoptysis, metatarsalgia, joint swelling, other symptoms referable to joint, hyperextension, cullen's sign, traumatic hematuria, mucosal haemorrhage, stiffness of joint, not elsewhere classified in icd10cm, nail bed hemorrhage

Drugs & Therapeutics for Hemarthrosis

About this section

Drugs for Hemarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1triamcinolone acetonidePhase 4463
2FACTOR VIIIPhase 4, Phase 3, Phase 2282
3
TriamcinolonePhase 4463124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
4
BenzocainePhase 4, Phase 317941994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
5
Hyaluronic acidPhase 44199004-61-953477741, 24759
Synonyms:
Hyaluronan
Hyaluronate
Hyaluronic acid
Hylartil
Hyruan Plus
Luronit
 
Macronan
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sofast
Synvisc
6
RopivacainePhase 470984057-95-471273, 175805
Synonyms:
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
L-N-n-propylpipecolic acid-2,6-xylidide
LS-113954
 
MLS001401363
MolPort-003-983-292
NCGC00164597-01
Naropin
Naropin (TN)
ROPIVACAINE HCl
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
SAM001246524
SMR000469137
ST51051452
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
7
BevacizumabPhase 41938216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
8tannic acidNutraceuticalPhase 4, Phase 31794
9
Povidone-iodine14425655-41-8
Synonyms:
 
Betadine
10Chlorhexidine gluconate448
11
Chlorhexidine44855-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
12THROMBIN284

Interventional clinical trials:

(show top 50)    (show all 68)
idNameStatusNCT IDPhase
1Viscosupplementation in Patients With Hemophilic ArthropathyCompletedNCT01748201Phase 4
2Trial of NovoSeven® in Haemophilia - Joint BleedsCompletedNCT00108797Phase 4
3High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsCompletedNCT00571584Phase 4
4Russian Kogenate Pediatric StudyCompletedNCT00632814Phase 4
5BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)CompletedNCT00586521Phase 4
6Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle ArthropathyCompletedNCT00638001Phase 4
7Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia ACompletedNCT02697370Phase 4
8Canadian Hemophilia Prophylaxis StudyCompletedNCT01085344Phase 4
9Prophylaxis Versus on Demand Treatment for Children With Hemophilia ACompletedNCT01810666Phase 4
10Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment RegimensCompletedNCT00927667Phase 4
11Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic SynovitisRecruitingNCT02060305Phase 4
12Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis RegimensRecruitingNCT02314325Phase 4
13Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia BCompletedNCT00364182Phase 3
14Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ACompletedNCT01458106Phase 3
15Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BCompletedNCT01440946Phase 3
16Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia ACompletedNCT01181128Phase 3
17Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia BRecruitingNCT02234310Phase 3
18A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without InhibitorsRecruitingNCT02847637Phase 3
19A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Patients With InhibitorsRecruitingNCT02622321Phase 3
20An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia ARecruitingNCT02234323Phase 3
21BAX 855 PK-Guided DosingRecruitingNCT02585960Phase 3
22A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia AActive, not recruitingNCT01580293Phase 2, Phase 3
23Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia BActive, not recruitingNCT01425723Phase 3
24Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia AEnrolling by invitationNCT01454739Phase 3
25Early Prophylaxis Immunologic Challenge (EPIC) StudyTerminatedNCT01376700Phase 3
26Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2
27Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIIICompletedNCT00245245Phase 2
28rFVIIa Prophylaxis in Children With Hemophilia A and InhibitorsActive, not recruitingNCT01105546Phase 2
29BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia ATerminatedNCT00623727Phase 2
30Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and InhibitorsCompletedNCT01234545
31Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee SurgeryCompletedNCT02752581
32Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic ArthropathyCompletedNCT02601170
33Manual Therapy in Haemophilic Arthropathy of the KneeCompletedNCT02198014
34Physiotherapy in the Haemophilic Arthropathy of the Elbow.CompletedNCT02198040
35Bilateral Deficit Phenomenon in Patients With Haemophilic ArthropathyCompletedNCT02165462
36The FEIBA NovoSeven Comparative StudyCompletedNCT00166309
37The Von Willebrand Disease (VWD) International Prophylaxis StudyCompletedNCT00557908
38Gait Evaluation in Haemophiliac PatientsCompletedNCT00824798
39Educational Physiotherapy in HaemophiliaCompletedNCT02825706
40Aspiration for Pain Relief Following Ankle FractureCompletedNCT01484535
41Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint DiseaseCompletedNCT00212485
42Prophylaxis Versus On-demand Therapy Through Economic ReportCompletedNCT01159587
43Impact of Pain on Functional Impairment and Quality of Life in Adults With HemophiliaCompletedNCT01988532
44Project to Update the Study of Congenital Haemophilia in SpainCompletedNCT01959555
45Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia ACompletedNCT02634723
46The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding LogsCompletedNCT00212459
47Ultrasonography in Hemophilic Joint Disease and Serum MarkersRecruitingNCT02634918
48Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A PatientsRecruitingNCT02622646
49Multidisciplinary Evaluation of Patients With HemophiliaRecruitingNCT02198430
50TGA (Thrombin Generation Assay) and Prophylaxis in HaemophiliaRecruitingNCT02781766

Search NIH Clinical Center for Hemarthrosis


Cochrane evidence based reviews: hemarthrosis

Genetic Tests for Hemarthrosis

About this section

Anatomical Context for Hemarthrosis

About this section

MalaCards organs/tissues related to Hemarthrosis:

34
Bone, B cells, Monocytes, Myeloid, Skeletal muscle

Animal Models for Hemarthrosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Hemarthrosis:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053857.4F10, F13A1, F7, F9, SPP1
2MP:00053767.4F10, F13A1, F7, F8, F9, SPP1
3MP:00107687.3F10, F13A1, F7, F8, F9, SPP1

Publications for Hemarthrosis

About this section

Articles related to Hemarthrosis:

(show top 50)    (show all 221)
idTitleAuthorsYear
1
Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review. (25417208)
2014
2
Occult Intra-articular Knee Injuries in Children With Hemarthrosis. (24753236)
2014
3
Recurrent hemarthrosis : an unusual cause. (23680622)
2013
4
Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. (24283895)
2013
5
Spontaneous recurrent hemarthrosis of the knee joint in the elderly: a report of two cases. (21607723)
2012
6
Intra-articular nodular fasciitis of the knee: a rare cause of recurrent hemarthrosis. (21431289)
2012
7
A rare case of meniscal hematoma with hemarthrosis of the knee: a case report. (21938355)
2011
8
Recurrent hemarthrosis in a boy with synovial hemangioma: a case report. (21088622)
2011
9
Recurrent hemarthrosis after unicompartmental knee arthroplasty. (21902161)
2011
10
Glanzmann thrombasthenia detected because of knee hemarthrosis: a case report. (20736850)
2010
11
Synovial hypertrophy causing recurrent hemarthrosis after total knee replacement. (20812578)
2010
12
Late recurrent hemarthrosis following knee arthroplasty associated with epithelioid angiosarcoma of bone. (19945286)
2010
13
Angiographic findings and therapeutic embolization of late hemarthrosis after total joint arthroplasty. (18773205)
2009
14
Acute traumatic hemarthrosis of the adult's knee--a diagnostic options in arthroscopic era. Literature review. (19133435)
2008
15
In vitro multipotentiality and characterization of human unfractured traumatic hemarthrosis-derived progenitor cells: A potential cell source for tissue repair. (17171634)
2007
16
Radiosynoviorthesis for treatment of hemophilic hemarthrosis--Slovenian experience. (15989481)
2005
17
Hemarthrosis associated with failure of a mobile meniscal-bearing total knee arthroplasty. A case report. (14668519)
2003
18
Therapeutic embolization for late hemarthrosis after total knee arthroplasty. A case report. (12954841)
2003
19
Hemarthrosis as initial presentation of scurvy. (11508601)
2001
20
Cytogenetic studies in patients with hemophilic hemarthrosis treated by 198Au, 186Rh, and 90Y radioactive synoviorthesis. (10647112)
2000
21
Decreased Quick percentage, acquired factor X deficiency, hemarthrosis and ecchymosis: amyloidosis]. (10517125)
1999
22
Effects of intra-articular vitamin E and corticosteroid injection in experimental hemarthrosis in rabbits. (9658435)
1998
23
Recurrent acute hemarthrosis after anterior cruciate ligament reconstruction. Report of an unusual complication and a review of the literature. (8739716)
1996
24
Minimal trauma knee hemarthrosis. (8731422)
1996
25
Recurrent hemarthrosis after total knee arthroplasty. (8986579)
1996
26
Recurrent hemarthrosis following a total knee arthroplasty. (8776057)
1995
27
Proteoglycan degradation in hemarthrosis. Intraarticular, autologous blood injection in rat knees. (7863774)
1995
28
Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment. (8259416)
1994
29
Reduction and osteosynthesis of subcapital fractures of the femoral neck: possible repercussions on post-fracture hemarthrosis of the hip. (1345649)
1992
30
Hemarthrosis in patients with acquired factor VIII inhibitor. (1902518)
1991
31
High-pressure hemarthrosis: possible consequences to the vascularization of the femoral head. (1816159)
1991
32
Hemarthrosis and oral anticoagulants. (1865684)
1991
33
Segond fracture, hemarthrosis, and anterior cruciate ligament disruption. (2351796)
1990
34
Hemarthrosis of the ankle secondary to false aneurysm caused by impingement from an osteophyte. A case report. (2745490)
1989
35
99mTc-DPD uptake in juvenile hemarthrosis. Scintimetry and autoradiography of the knee in dogs. (2710706)
1989
36
The significance of hemarthrosis of the knee in children. (3358674)
1988
37
Obstructive sleep apnea caused by hemarthrosis-induced micrognathia. (3817070)
1987
38
A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosis. (3917602)
1985
39
Spontaneous hemarthrosis in a patient treated with hemodialysis for chronic renal failure. (7138610)
1982
40
Hemarthrosis: a review of the literature. (6991586)
1980
41
Hemarthrosis of the temporomandibular joint in a patient with hemophilia B: report of case. (286767)
1979
42
Hemarthrosis with sodium warfarin and heparin. (737008)
1978
43
Hemarthrosis in an heparinized patient. (856220)
1977
44
On the pathogenesis of hemophilic hemarthrosis]. (808446)
1975
45
Hemarthrosis. (1053879)
1975
46
The management of deep soft tissue bleeding and hemarthrosis in hemophilia. (5011042)
1972
47
Management of hemarthrosis. (5440065)
1970
48
Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia. (4907066)
1970
49
Treatment of hemarthrosis in hemophilia. (5448344)
1970
50
The use of hyaluronidase in the treatment of acute hemophilic hemarthrosis. (13035639)
1953

Variations for Hemarthrosis

About this section

Expression for genes affiliated with Hemarthrosis

About this section
Search GEO for disease gene expression data for Hemarthrosis.

Pathways for genes affiliated with Hemarthrosis

About this section

Pathways related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 11)
idSuper pathwaysScoreTop Affiliating Genes
19.3BGLAP, SPP1
29.3BGLAP, SPP1
39.3BGLAP, SPP1
49.3BGLAP, SPP1
58.2BGLAP, F10, F7, F9
6
Show member pathways
8.2BGLAP, F10, F7, F9
7
Show member pathways
7.9F10, F13A1, F7, F8, F9
8
Show member pathways
7.9F10, F13A1, F7, F8, F9
9
Show member pathways
7.9F10, F13A1, F7, F8, F9
10
Show member pathways
7.9F10, F13A1, F7, F8, F9
11
Show member pathways
7.8BGLAP, F10, F7, F8, F9

GO Terms for genes affiliated with Hemarthrosis

About this section

Cellular components related to Hemarthrosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:003109310.2F13A1, F8
2membrane-bounded vesicleGO:003198810.0BGLAP, SPP1
3cell projectionGO:00429959.3BGLAP, SPP1
4Golgi lumenGO:00057968.6BGLAP, F10, F7, F9
5endoplasmic reticulum lumenGO:00057888.0BGLAP, F10, F7, F8, F9
6extracellular spaceGO:00056157.4BGLAP, F7, F8, F9, SPP1
7extracellular regionGO:00055766.6BGLAP, F10, F13A1, F7, F8, F9

Biological processes related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1platelet degranulationGO:000257610.0F13A1, F8
2blood coagulation, intrinsic pathwayGO:00075979.8F10, F8, F9
3response to vitamin KGO:00325719.6BGLAP, F7
4positive regulation of protein kinase B signalingGO:00518979.6F10, F7
5response to vitamin DGO:00332809.5BGLAP, SPP1
6osteoblast differentiationGO:00016499.4BGLAP, SPP1
7blood coagulation, extrinsic pathwayGO:00075989.4F10, F7, F9
8response to estrogenGO:00436279.2BGLAP, F7
9response to nutrient levelsGO:00316679.0BGLAP, F7
10peptidyl-glutamic acid carboxylationGO:00171878.7BGLAP, F10, F7, F9
11signal peptide processingGO:00064658.7BGLAP, F10, F7, F9
12ER to Golgi vesicle-mediated transportGO:00068888.1BGLAP, F10, F7, F8, F9
13blood coagulationGO:00075967.9F10, F13A1, F7, F8, F9

Molecular functions related to Hemarthrosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endopeptidase activityGO:00041759.6F7, F9
2serine-type endopeptidase activityGO:00042528.6F10, F7, F8, F9
3calcium ion bindingGO:00055098.2BGLAP, F10, F7, F9

Sources for Hemarthrosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet